Related Experiment Video
Updated: Jun 7, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
An Integrated Dataset of Clinical and Microbial Profiles for Fecal Microbiota Transplantation
Sen Yan1, Le Wang2,3, Yue Xu2,3
1Department of Clinical Laboratory, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
Abstract:
Functional gastrointestinal disorders (FGIDs) are prevalent and burdensome, yet progress in microbiota-targeted therapies such as fecal microbiota transplantation (FMT) has been hampered by the lack of large-scale, integrated datasets. Current studies are mostly limited in sample size and scope, constraining mechanistic insight and precision application. To address this gap, we established FMTdb, a curated dataset focused on FGID patients treated with FMT. This resource integrates demographic, clinical, and multi-omic microbiota data from 15 rigorously screened long-term donors, 370 FGID recipients, and 2,008 healthy community controls. Longitudinal metadata include donor follow-up and pre- and post-treatment observations of recipients across multiple time points. By providing a multi-layered dataset that connects microbial composition with host response, FMTdb offers a robust platform for biomarker discovery, mechanistic exploration, and the development of personalized microbiota-based interventions for FGIDs.
Insights
A new dataset, FMTdb, integrates microbiota data from functional gastrointestinal disorder (FGID) patients receiving fecal microbiota transplantation (FMT). This resource aids in discovering biomarkers and developing personalized FGID treatments.
Area of Science:
- Microbiome research
- Gastroenterology
- Data science
Background:
- Functional gastrointestinal disorders (FGIDs) are common and debilitating.
- Microbiota-targeted therapies like fecal microbiota transplantation (FMT) show promise but lack large-scale data for mechanistic insights and personalized application.
- Existing studies are limited in scope and sample size.
Purpose of the Study:
- To establish FMTdb, a comprehensive, integrated dataset for FGID patients undergoing FMT.
- To facilitate biomarker discovery and mechanistic exploration in FGIDs.
- To support the development of personalized, microbiota-based interventions for FGIDs.
Main Methods:
- Curated a dataset integrating demographic, clinical, and multi-omic microbiota data.
- Included data from 15 screened long-term donors, 370 FGID recipients, and 2,008 healthy controls.
- Collected longitudinal metadata on donor follow-up and recipient pre/post-treatment observations.
Main Results:
- FMTdb provides a multi-layered dataset connecting microbial composition with host response.
- The dataset enables robust analysis of microbiota alterations in FGID patients treated with FMT.
- Facilitates identification of potential biomarkers and therapeutic targets.
Conclusions:
- FMTdb serves as a valuable resource for advancing FGID research.
- The integrated data supports the development of precision medicine approaches for FGIDs.
- This platform is crucial for understanding FMT efficacy and optimizing microbiota-based therapies.
Related Concept Videos
Microbiota of the Large Intestine
Introduction to the Human Microbiota
Microbiota of the Urogenital Tract
Microbiota Modulation by Antibiotics
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Development of Human Microbiota
